The Pursuit of "Best" Anticoagulant for Cancer-Associated Thrombosis: Are We There Yet?

JACC CardioOncol. 2024 Jan 9;6(1):114-116. doi: 10.1016/j.jaccao.2023.12.001. eCollection 2024 Feb.

Authors

Tzu-Fei Wang¹, Jean M Connors²

Affiliations

¹ Department of Medicine, University of Ottawa at The Ottawa Hospital and Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
² Division of Hematology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.

No abstract available

Keywords: anticoagulation; direct oral anticoagulant; low molecular weight heparin; neoplasia; venous thromboembolism.

Publication types

Editorial